Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 41.78-15.6018.7817.2359.00

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 41.78 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202441.78
Mar2023-15.60
Mar202218.78
Mar202117.23
Mar202059.00

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2024 41.78
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23
-70.80
Mar2020 59 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,385.9 Cr -2.7% 6.6% 33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,025.0 Cr -0.4% 4.7% 60.2% Stock Analytics
DIVIS LABORATORIES ₹144,299.0 Cr -1.1% 11% 43.2% Stock Analytics
CIPLA ₹132,316.0 Cr -1.3% 2.8% 33.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,579.0 Cr -2.3% -7.8% 14.4% Stock Analytics
ZYDUS LIFESCIENCES ₹106,092.0 Cr -5.7% -12.6% 68.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.7%

6.6%

33.4%

SENSEX

0.3%

3%

23.3%


You may also like the below Video Courses